English | Español
Gene Johnson | Mar 24, 2017

China approves Xeljanz to treat moderate to severe rheumatoid arthritis
Gene Johnson | Mar 24, 2017

Japan to review drug for the treatment of chronic hepatitis C
Gene Johnson | Mar 24, 2017

FDA approves new drug for the treatment of advanced breast cancer in women

Robert Hadley | Mar 23, 2017

Eli Lilly’s Taltz show better results than rival Stelara in clinical trials
John Breslin | Mar 23, 2017

Lawmakers promise timely renewal of drug fee agreements

Robert Hadley | Mar 22, 2017

Study shows improvement in severe asthma cases with use of Nucala
Robert Hadley | Mar 22, 2017

New drug may prolong remission in ovarian cancer patients
Robert Hadley | Mar 22, 2017

Amgen’s Repatha may help patients with tough cases of high cholesterol

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’